SUMMARY
The research of Nadine H. Abdallah, M.D., studies the impact of frailty, body composition and social determinants of health on treatment outcomes in older patients with multiple myeloma and related disorders.
Dr. Abdallah's research personalizes treatment strategies by incorporating geriatric assessments. She also evaluates ways to reduce treatment-related toxicity and improve the quality of life of older patients who are receiving cancer-directed treatment.
Focus areas
- Comprehensive geriatric assessment of patients with cancer. Dr. Abdallah researches the impact of geriatric assessment domains on treatment outcomes of patients with multiple myeloma. She evaluates models for incorporating comprehensive geriatric assessment in the clinical hematology practice using digital health technologies.
- Body composition in multiple myeloma. Dr. Abdallah focuses on the impact of body composition and physical function on treatment outcomes of patients with multiple myeloma.
- Risk stratification in multiple myeloma. Dr. Abdallah studies the influence of chromosomal irregularities known as cytogenetic abnormalities. Her goal is to improve risk stratification for patients by better understanding how these irregularities affect prognosis.
Significance to patient care
Dr. Abdallah is studying ways to implement geriatric assessment into the clinical practice. She also investigates ways to improve the physical function and treatment tolerability of older patients with multiple myeloma and related plasma cell disorders.
Her work improves the quality of care of older patients with cancer and plasma cell disorders and advances treatment outcomes and quality of life in this population.
Professional highlights
- Kern Health Care Delivery Scholar, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, 2023-2026.